Child Categories
Food & Drug Law
-
Ten Years Post-GAO Assessment, FDA Remains Uninformed of Potentially Harmful GRAS Substances in Foods
October 7, 2025
Cameron Faustman, Daniel Aaron, Nicole Negowetti & Emily Broad Leib, Ten Years Post-GAO Assessment, FDA Remains Uninformed of Potentially Harmful GRAS Substances in Foods, 61…
-
A Call to Action: The New Academy of Food Law & Policy
October 7, 2025
Emily M. Broad Leib & Susan A. Schneider, A Call to Action: The New Academy of Food Law & Policy, 13 J. Food L. &…
-
Food Law & Policy: An Essential Part of Today’s Legal Academy
October 7, 2025
Emily M. Broad Leib & Baylen J. Linnekin, Food Law & Policy: An Essential Part of Today’s Legal Academy, 13 J. Food L. & Pol’y…
-
The Future of Food Law & Policy: The Responsibility of Lawyers in the Academy and Beyond
October 7, 2025
Baylen J. Linnekin, Susan A. Schneider, Emily Broad Leib, Margaret Sova McCabe, Laurie Ristino & Michael Roberts, The Future of Food Law & Policy: The…
-
Laurie J. Beyranevand & Emily M. Broad Leib, Making the Case for a National Food Strategy in the United States, 72 Food & Drug L.J.
-
Food and the Law
October 7, 2025
Baylen J. Linnekin & Emily M. Broad Leib, Food and the Law, in Routledge International Handbook of Food Studies 238 (Ken Albala ed., 2013).
-
Fresh Look At Organics Bans And Waste Recycling Laws
October 7, 2025
Emily Broad Leib et al., Fresh Look At Organics Bans And Waste Recycling Laws, 57 BioCycle 16 (2016).
-
Carmel Shachar, Philip A. Gruppuso & Eli Y. Adashi, Pediatric Drug and Other Shortages in the Age of Supply Chain Disruption, 329 JAMA 2127 (2023).
-
The US FDA’s New Rule for Regulating Laboratory-Developed Tests
October 2, 2025
Daniel G. Aaron, Eli Y. Adashi & I. Glenn Cohen, The US FDA’s New Rule for Regulating Laboratory-Developed Tests, 5 JAMA Health F. (2024).
-
Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement
October 2, 2025
Amy L. McGuire, I. Glenn Cohen, Dominic Sisti et al., Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement, 7 JAMA…
-
Food and Drug Omnibus Reform Act: A Critical Course Correction
October 2, 2025
Aditya Narayan, I. Glenn Cohen & Eli Y. Adashi, Food and Drug Omnibus Reform Act: A Critical Course Correction, 99 Mayo Clinic Proc. 869 (2024).
-
Eli Y. Adashi, Daniel P. O’Mahony & I. Glenn Cohen, The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional, Am. J. Med.
-
Pressing Regulatory Challenges for Psychedelic Medicine
October 2, 2025
Amy L. McGuire, Holly Fernandez Lynch, Lewis A. Grossman et al., Pressing Regulatory Challenges for Psychedelic Medicine, 380 Science 347 (2023).
-
Eli Y. Adashi & I. Glenn Cohen, The CMS Vaccine Mandate at the Supreme Court: A Hippocratic Imperative, Am. J. Med. (2022).
-
David A. Simon, Carmel Shachar & I. Glenn Cohen, At-home Diagnostics and Diagnostic Excellence: Devices vs General Wellness Products, 327 JAMA 523 (2022).
-
Machine Learning in Medicine: Addressing Ethical Challenges
September 30, 2025
Effy Vayena, Alessandro Blasimme & I. Glenn Cohen, Machine Learning in Medicine: Addressing Ethical Challenges, 15 PLoS Med. e1002689 (2018).
-
Obesity Prevention in the Supermarket—Choice Architecture and the Supplemental Nutrition Assistance Program
September 30, 2025
Cass R. Sunstein (with Anne Thorndike), Obesity Prevention in the Supermarket–Choice Architecture and the Supplemental Nutrition Assistance Program, 107 Am. J. Pub. Health 1582 (2017).
-
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
September 30, 2025
Soumitri Barua, Robert Greenwald, Jason Grebely, Gregory J. Dore, Tracy Swan & Lynn E. Taylor, Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of…
-
When Clinical Trials Compete: Prioritising Study Recruitment
September 30, 2025
Luke Gelinas, Holly Fernandez Lynch, Barbara E. Bierer & I. Glenn Cohen, When Clinical Trials Compete: Prioritising Study Recruitment, 43 J. Med. Ethics 803 (2017).
-
FDA Regulation of Mobile Health Technologies
September 30, 2025
Nathan G. Cortez, I. Glenn Cohen & Aaron S. Kesselheim, FDA Regulation of Mobile Health Technologies, 370 New Eng. J. Med. 372 (2014).
-
The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine
September 29, 2025
Craig M. Klugman, Laura B. Dunn, Jack Schwartz & I. Glenn Cohen, The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at…